Cargando…

THE SURREPTITIOUS ADMINISTRATION OF CLOZAPINE: CRITICAL ISSUES

Detalles Bibliográficos
Autores principales: Pfizer, N., Andrade, Chittaranjan
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954352/
https://www.ncbi.nlm.nih.gov/pubmed/21206570
_version_ 1782187921832411136
author Pfizer, N.
Andrade, Chittaranjan
author_facet Pfizer, N.
Andrade, Chittaranjan
author_sort Pfizer, N.
collection PubMed
description
format Text
id pubmed-2954352
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-29543522011-01-04 THE SURREPTITIOUS ADMINISTRATION OF CLOZAPINE: CRITICAL ISSUES Pfizer, N. Andrade, Chittaranjan Indian J Psychiatry Letters to Editor Medknow Publications 2002 /pmc/articles/PMC2954352/ /pubmed/21206570 Text en Copyright: © Indian Journal of Psychiatry http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to Editor
Pfizer, N.
Andrade, Chittaranjan
THE SURREPTITIOUS ADMINISTRATION OF CLOZAPINE: CRITICAL ISSUES
title THE SURREPTITIOUS ADMINISTRATION OF CLOZAPINE: CRITICAL ISSUES
title_full THE SURREPTITIOUS ADMINISTRATION OF CLOZAPINE: CRITICAL ISSUES
title_fullStr THE SURREPTITIOUS ADMINISTRATION OF CLOZAPINE: CRITICAL ISSUES
title_full_unstemmed THE SURREPTITIOUS ADMINISTRATION OF CLOZAPINE: CRITICAL ISSUES
title_short THE SURREPTITIOUS ADMINISTRATION OF CLOZAPINE: CRITICAL ISSUES
title_sort surreptitious administration of clozapine: critical issues
topic Letters to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2954352/
https://www.ncbi.nlm.nih.gov/pubmed/21206570
work_keys_str_mv AT pfizern thesurreptitiousadministrationofclozapinecriticalissues
AT andradechittaranjan thesurreptitiousadministrationofclozapinecriticalissues
AT pfizern surreptitiousadministrationofclozapinecriticalissues
AT andradechittaranjan surreptitiousadministrationofclozapinecriticalissues